Tarlatamab (AMG-757) is a bispecific T cell engager (BiTE) antibody targeting DLL3 and CD3, with human DLL3 and CD3 KD = 0.64 nM/14.9 nM, for use in immuno-oncology therapy of small cell lung cancer (SCLC).
Purity:
95.00%
CAS Number:
[2307488-83-9]
Target:
Gamma-secretase|||Integrin
* VAT and and shipping costs not included. Errors and price changes excepted